Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
12 Jul 2023
// Max Bayer FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/liminal-takes-buyout-top-shareholder-peach-price
09 Jan 2023
// Max Bayer FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/annexon-liminal-shrink-pipelines-prioritize-potential-homerun-candidates
29 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/liminal-biosciences-to-present-at-hc-wainwright-24th-annual-global-investment-conference-301613447.html
27 Aug 2022
// BIOPHARMA APAC
https://biopharmaapac.com/news/48/1931/liminal-biosciences-announces-termination-of-legacy-cdmo-contract.html
23 May 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/liminal-biosciences-announces-first-subject-dosed-in-phase-1a-single-ascending-dose-clinical-trial-of-fezagepras-301552529.html
27 Jan 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/01/27/2374469/0/en/Ocugen-Inc-Signs-Letter-of-Intent-to-Acquire-Vaccine-Manufacturing-R-D-Hub-in-Ontario-Canada.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?